Skip to content
WeighLab

Ivim Health vs Maves

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Ivim Health

Provider comparison

Shoppers ready to commit to a multi-month program who want weekly check-ins, or insured shoppers who want help getting brand-name Wegovy or Zepbound covered.

Semaglutide / month
$149.99/mo6-month program, starting dose, medication and program fee, compounded
Tirzepatide / month
$207.99/mo6-month program, starting dose, medication and program fee, compounded
Index 61/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Ivim Health pricing Read review

Maves

Provider comparison

Readers comparing ongoing compounded GLP-1 prices who want named clinical leadership and will confirm state eligibility.

Semaglutide / month
$249/moOngoing (compounded; first month $189)
Tirzepatide / month
$349/moOngoing (compounded; first month $249)
Index 60/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Maves pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Ivim Health has the higher Cost-Efficiency Index: 61/100 versus 60/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

Ivim Health
Coverage not published
Maves
Select U.S. states; list not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Ivim Health

Maves

Semaglutide / month
Ivim Health: $149.99/mo6-month program, starting dose, medication and program fee, compounded
Maves: $249/moOngoing (compounded; first month $189)
Tirzepatide / month
Ivim Health: $207.99/mo6-month program, starting dose, medication and program fee, compounded
Maves: $349/moOngoing (compounded; first month $249)
Semaglutide / year (modeled)
Ivim Health: $1,800
Maves: $2,988
Tirzepatide / year (modeled)
Ivim Health: $2,496
Maves: $4,188
State availability
Ivim Health: Coverage not published
Maves: Select U.S. states; list not published
Oral / sublingual option listed
Ivim Health: Yes
Maves: Not listed
Brand-name access listed
Ivim Health: Yes
Maves: Not confirmed
Provider facts checked
Ivim Health: October 2026
Maves: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Ivim Health

Shoppers ready to commit to a multi-month program who want weekly check-ins, or insured shoppers who want help getting brand-name Wegovy or Zepbound covered.

Reasons to consider it

  • Publishes six-month rates: compounded semaglutide $75 and tirzepatide $133 a month, plus the $74.99 monthly program fee
  • Also prescribes brand-name Wegovy, the Wegovy pill, Foundayo, Zepbound and others, with an insurance team that handles prior authorizations
  • Weekly app check-ins and refills timed to your plan, with dose adjustments by your provider

What to weigh up

  • Programs run one, two, four or six months, and the FAQ says you can't cancel once a program starts; leaving early can cost $50 or $100 per unshipped portion
  • No month-to-month price is published: the advertised rates are six-month rates, and the cost at a higher dose isn't shown
  • Doesn't name its pharmacy or list the states it serves

Regulatory note: the FDA issued a warning letter to Ivim Services LLC dba Ivim in February 2026. We still list and link to Ivim Health; you should know the letter is on the public record before you decide.

Compounded drugs are not FDA-approved. Understand the medication options.

Check Ivim Health pricing Read the full Ivim Health review

Maves

Readers comparing ongoing compounded GLP-1 prices who want named clinical leadership and will confirm state eligibility.

Reasons to consider it

  • Publishes the introductory and ongoing price for each injectable medication
  • Names Dr. Michael Green as chief medical officer
  • Clinician review, dose adjustments, 24/7 messaging and shipping are included

What to weigh up

  • Availability varies by state and no treatment-specific state list is published
  • The dispensing pharmacies are not named
  • First-month discounts do not continue into later monthly bills

Compounded drugs are not FDA-approved. Understand the medication options.

Check Maves pricing Read the full Maves review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

Ivim HealthMaves
Normalized Cost/Month
Ivim Health:
62/100
Maves:
52/100
Price Transparency
Ivim Health:
78/100
Maves:
86/100
Nationwide Access
Ivim Health:
24/100
Maves:
24/100
Formulation Options
Ivim Health:
95/100
Maves:
66/100
Clinical Oversight
Ivim Health:
79/100
Maves:
88/100
Contract Flexibility
Ivim Health:
20/100
Maves:
49/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to Ivim HealthAlternatives to Maves
More provider matchups
CoreAge Rx vs Ivim HealthCoreAge Rx vs Maves
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.